Discrepant Bowel Perforation from a Primary Lesion after Chemotherapy of Diffuse Large B Cell Lymphoma
Journal of the Korean Surgical Society
;
: 61-65, 2009.
Artículo
en Inglés
| WPRIM
| ID: wpr-170258
ABSTRACT
Diffuse large B cell lymphoma is the most common type of non-Hodgkin's lymphoma, representing approximately one-third of all cases and involving the gastrointestinal tract in about 18%. With the development of modern chemotherapeutic regimens and advances in medical care, the prognosis for malignant lymphoma can be excellent. However, because of the aggressive adjuvant therapy required, complications such as bowel perforation may be fatal. In cases of chemotherapy for malignant lymphoma, we should keep in mind the possibility of perforation of the bowel after chemotherapy. Early detection is important to save patients.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pronóstico
/
Linfoma no Hodgkin
/
Linfoma de Células B
/
Tracto Gastrointestinal
/
Linfoma
Tipo de estudio:
Estudio pronóstico
/
Estudio de tamizaje
Límite:
Humanos
Idioma:
Inglés
Revista:
Journal of the Korean Surgical Society
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS